CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

FDA Rare Disease Innovation Hub

RegulatoryNeutral
AI Analysis

Summary

FDA created the Rare Disease Innovation Hub to connect CBER and CDER and support collaboration between them. The stated goal is to improve outcomes for patients with rare diseases.

Importance:2/10
Sentiment:
0.20
FDArare diseaseCBERCDERregulatory policy

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on October 14, 2026 7:45 PM

Read Original